Nervonik

Nervonik

The company's mission is to develop a new generation of implantable devices that can modulate the nervous system to treat a variety of conditions, including chronic pain, epilepsy, and parkinson's disease.

HQ location
Los Angeles, United States
Launch date
Employees
Enterprise value
$52—78m
Authorizing premium user...